-
Something wrong with this record ?
FosA8-producing E. coli ST131: clinical cases in Italy, February 2023
K. Chudejova, MS. Caltagirone, V. Mattioni Marchetti, A. Rezzani, A. Navarra, I. Bitar
Language English Country Sweden
Document type Journal Article, Case Reports
NLK
Directory of Open Access Journals
from 1996
Free Medical Journals
from 1995
Freely Accessible Science Journals
from 1995-09-01
PubMed Central
from 2016
Europe PubMed Central
from 2016
Open Access Digital Library
from 1996-01-01
Open Access Digital Library
from 2016-01-01
Medline Complete (EBSCOhost)
from 2010-07-01
ROAD: Directory of Open Access Scholarly Resources
from 1995
- MeSH
- Anti-Bacterial Agents * pharmacology therapeutic use MeSH
- Drug Resistance, Bacterial MeSH
- beta-Lactamases genetics metabolism MeSH
- Escherichia coli * isolation & purification genetics drug effects MeSH
- Fosfomycin pharmacology therapeutic use MeSH
- Escherichia coli Infections * microbiology epidemiology MeSH
- Humans MeSH
- Microbial Sensitivity Tests MeSH
- Multilocus Sequence Typing MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
- Geographicals
- Italy MeSH
Fosfomycin-resistant FosA8-producing Enterobacterales are uncommon strains with extremely low incidence in Europe, based on only three reports in the literature. We detected FosA8-producing Escherichia coli ST131 in clinical isolates from two patients admitted in February 2023 to a rehabilitation unit in Italy. The occurrence of rare fosA-like genes in the high-risk clone ST131 is of clinical relevance. The dissemination of FosA-producing E. coli, although still at low levels, should be continuously monitored.
Biomedical Center Faculty of Medicine Charles University Pilsen Czechia
Microbiology Unit IRCCS Istituti Clinici Scientifici Maugeri Pavia Italy
Specialization School of Microbiology and Virology University of Pavia Pavia Italy
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24014024
- 003
- CZ-PrNML
- 005
- 20240905134120.0
- 007
- ta
- 008
- 240725s2024 sw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.2807/1560-7917.ES.2024.29.21.2400276 $2 doi
- 035 __
- $a (PubMed)38785090
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sw
- 100 1_
- $a Chudejova, Katerina $u Department of Microbiology, Faculty of Medicine, University Hospital in Pilsen, Charles University, Pilsen, Czechia $u Biomedical Center, Faculty of Medicine, Charles University, Pilsen, Czechia
- 245 10
- $a FosA8-producing E. coli ST131: clinical cases in Italy, February 2023 / $c K. Chudejova, MS. Caltagirone, V. Mattioni Marchetti, A. Rezzani, A. Navarra, I. Bitar
- 520 9_
- $a Fosfomycin-resistant FosA8-producing Enterobacterales are uncommon strains with extremely low incidence in Europe, based on only three reports in the literature. We detected FosA8-producing Escherichia coli ST131 in clinical isolates from two patients admitted in February 2023 to a rehabilitation unit in Italy. The occurrence of rare fosA-like genes in the high-risk clone ST131 is of clinical relevance. The dissemination of FosA-producing E. coli, although still at low levels, should be continuously monitored.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a Escherichia coli $x izolace a purifikace $x genetika $x účinky léků $7 D004926
- 650 12
- $a infekce vyvolané Escherichia coli $x mikrobiologie $x epidemiologie $7 D004927
- 650 12
- $a antibakteriální látky $x farmakologie $x terapeutické užití $7 D000900
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 650 _2
- $a fosfomycin $x farmakologie $x terapeutické užití $7 D005578
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a beta-laktamasy $x genetika $x metabolismus $7 D001618
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a bakteriální léková rezistence $7 D024881
- 650 _2
- $a multilokusová sekvenční typizace $7 D058885
- 651 _2
- $a Itálie $x epidemiologie $7 D007558
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a kazuistiky $7 D002363
- 700 1_
- $a Caltagirone, Maria Sofia $u Microbiology Unit, IRCCS Istituti Clinici Scientifici Maugeri, Pavia, Italy
- 700 1_
- $a Mattioni Marchetti, Vittoria $u Scienze Clinico, Chirurgiche, Diagnostiche, Pediatriche Department, Microbiology Unit, University of Pavia, Pavia, Italy $u Specialization School of Microbiology and Virology, University of Pavia, Pavia, Italy
- 700 1_
- $a Rezzani, Antonella $u Microbiology Unit, IRCCS Istituti Clinici Scientifici Maugeri, Pavia, Italy
- 700 1_
- $a Navarra, Antonella $u Microbiology Unit, IRCCS Istituti Clinici Scientifici Maugeri, Pavia, Italy
- 700 1_
- $a Bitar, Ibrahim $u Department of Microbiology, Faculty of Medicine, University Hospital in Pilsen, Charles University, Pilsen, Czechia $u Biomedical Center, Faculty of Medicine, Charles University, Pilsen, Czechia
- 773 0_
- $w MED00174364 $t Euro surveillance $x 1560-7917 $g Roč. 29, č. 21 (2024)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38785090 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240725 $b ABA008
- 991 __
- $a 20240905134114 $b ABA008
- 999 __
- $a ok $b bmc $g 2143674 $s 1225890
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 29 $c 21 $e - $i 1560-7917 $m Euro surveillance $n Euro Surveill $x MED00174364
- LZP __
- $a Pubmed-20240725